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Items for this week’s Epi Update include: 
• Guidance for caring for individuals recently evacuated from Afghanistan 
• Changes to legionellosis investigations, reminder of preferred diagnostic tests 
• Fungus among us? 
• In the news: CDC statement on ACIP booster recommendations 
• Infographic: How to recognize MIS-C 
 
Guidance for caring for individuals recently evacuated from Afghanistan 
CDC has issued a Health Advisory recommending that clinicians be on alert for cases of 
measles, as well as other infectious diseases, including mumps, leishmaniasis, and malaria, 
among evacuees from Afghanistan. Clinicians should also recommend MMR vaccine for 
unvaccinated patients. As of September 20, CDC has been notified of 16 confirmed cases of 
measles among Afghan nationals and U.S. citizens recently arriving from Afghanistan. In 
addition to MMR vaccination, CDC recommends that evacuees are also up to date on 
vaccinations for varicella, polio, COVID-19, and seasonal influenza. 
 
If you suspect a patient may have measles, contact CADE immediately at 515-242-5935 
during business hours or 515-323-4360 outside of business hours. 
 
To view the full Health Advisory, visit emergency.cdc.gov/han/2021/han00452.asp.  
 
Changes to legionellosis investigations, reminder of preferred diagnostic tests 
IDPH and local public health partners work with laboratories and health care providers to 
identify potential sources of infection associated with multiple cases of legionellosis and 
provide guidance for reducing the risk from implicated sources. Potential sources include 
health care facilities, overnight stays in hotels, and hot tubs or other sources of water aeration. 
 
To better capture risk factor data, IDPH has made changes to legionellosis disease 
investigation and reporting. Investigators now ask about respiratory equipment, such as a 
CPAP machine, as these can be a risk for Legionella and other waterborne pathogens if not 
using sterile water or cleaning them properly. Information gathered about health care and 
water exposures also now more clearly describe potential risks. Full public health investigation 
guidance can be found in the IDPH epi manual at 
wiki.idph.iowa.gov/epimanual/Home/CategoryID/91.  
Health care providers should consider legionellosis in patients presenting with cough, fever, 
and pneumonia, especially those with a history of overnight travel, immune suppression, or 
health care visits within the two weeks before symptom onset. For more clinical information 
about Legionella, visit www.cdc.gov/legionella/downloads/fs-legionella-clinicians.pdf.  
 
The recommended tests for diagnosing legionellosis are BOTH a culture of a lower respiratory 
specimen on selective media AND the Legionella urine antigen test. The urine antigen test 
produces a quick result, but it only detects Legionella pneumophila serogroup 1. Therefore, a 
patient with a negative urinary antigen test may still have Legionnaires’ disease caused by 
other Legionella species or serogroup. Cultures can detect multiple species and serogroups, 
and allows for comparison of clinical and environmental isolates to identify possible sources of 
infection. Specimens sent to SHL for Legionella culture can also be tested by PCR, which has 
a quicker turnaround time than culture. SHL also performs Legionella cultures from clinical 
specimens and environmental sources.  
 
Contact SHL at 319-335-4500 if you are interested in submitting a specimen for culture and/or 
PCR, or visit the SHL links below for collection and submission instructions. 
 
Culture: www.shl.uiowa.edu/testmenu/menupages/legionella.xml  
PCR: www.shl.uiowa.edu/testmenu/menupages/legionellapcr.xml  
 
Fungus among us? 
Today marks the end of Fungal Disease Awareness week, when CDC and partners highlight 
the importance of recognizing serious fungal diseases early enough in the course of a patient’s 
illness to provide life-saving treatment. 
 
Some fungal diseases go undiagnosed, leading to serious illness and death. Increased 
awareness about fungal diseases is one of the most important ways to improve early 
recognition and reduce delays in diagnosis and treatment. A key clue to when a sick person 
may have a fungal disease is when they are being treated with medicine for another type of 
infection but do not get better. This has proven especially true during the COVID-19 pandemic 
where large clusters of pan-resistant and echinocandin-resistant Candida auris were seen in 
healthcare facilities in both Texas and the District of Columbia. 
 
CDC has a collection of resources including web features, fact sheets, and posters for 
healthcare facilities available at www.cdc.gov/fungal/awareness-week.html.  
 
CDC has also created a short patient education video to raise awareness of fungal diseases, 
available at youtu.be/BSpqTb7aM-c.  
 
Candida auris infection or colonization is a reportable condition in Iowa. Questions regarding 
the laboratory isolation of Candida auris and other fungal pathogens can be directed to the 
SHL’s Microbiology Department at 319-335-4335. 
 





Infographic: How to recognize MIS-C 
 
 
To view in full size, visit www.cdc.gov/mis/mis-c/hcp/provider-resources/index.html.  
 
Have a healthy and happy week! 
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